Literature DB >> 18800026

A rat model of chronic kidney disease-mineral bone disorder.

Sharon M Moe1, Neal X Chen, Mark F Seifert, Rachel M Sinders, Dana Duan, Xianming Chen, Yun Liang, J Scott Radcliff, Kenneth E White, Vincent H Gattone.   

Abstract

Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) is a newly defined syndrome encompassing patients with chronic kidney disease that have a triad of biochemical alterations in calcium, phosphorus and parathyroid hormone, vascular calcification, and bone abnormalities. Here we describe a novel Cy/+ rat model of slowly progressive kidney disease spontaneously developing the three components of CKD-MBD when fed a normal phosphorus diet. Since the renal disorder progressed 'naturally' we studied the effect of dietary manipulation during the course of the disease. Animals with early, but established, chronic kidney disease were fed a casein-based or a grain-based protein diet both of which had equivalent total phosphorus contents. The two different sources of dietary protein had profound effects on the progression of CKD-MBD, likely due to differences in intestinal bioavailability of phosphorus. Although both dietary treatments resulted in the same serum phosphorous levels, the casein-fed animals had increased urinary phosphorus excretion and elevated serum FGF23 compared to the grain-fed rats. This model should help identify early changes in the course of chronic kidney disease that may lead to CKD-MBD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18800026      PMCID: PMC2716076          DOI: 10.1038/ki.2008.456

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

Review 1.  Chronic kidney disease-mineral-bone disorder: a new paradigm.

Authors:  Sharon M Moe; Tilman Drüeke; Norbert Lameire; Garabed Eknoyan
Journal:  Adv Chronic Kidney Dis       Date:  2007-01       Impact factor: 3.620

2.  Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.

Authors:  Joanna H Brown; Marie-Thérèse Bihoreau; Sigrid Hoffmann; Bettina Kränzlin; Iulia Tychinskaya; Nicholas Obermüller; Dirk Podlich; Suzanne N Boehn; Pamela J Kaisaki; Natalia Megel; Patrick Danoy; Richard R Copley; John Broxholme; Ralph Witzgall; Mark Lathrop; Norbert Gretz; Dominique Gauguier
Journal:  J Am Soc Nephrol       Date:  2005-10-05       Impact factor: 10.121

3.  Modification of polycystic kidney disease and fatty acid status by soy protein diet.

Authors:  M R Ogborn; E Nitschmann; H A Weiler; N Bankovic-Calic
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

4.  Uremia-related vascular calcification: more than apatite deposition.

Authors:  S C Verberckmoes; V Persy; G J Behets; E Neven; A Hufkens; H Zebger-Gong; D Müller; D Haffner; U Querfeld; S Bohic; M E De Broe; P C D'Haese
Journal:  Kidney Int       Date:  2006-12-06       Impact factor: 10.612

5.  Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins.

Authors:  Neal X Chen; Kalisha D O'Neill; Xianming Chen; Danxia Duan; Exing Wang; Michael S Sturek; Jason M Edwards; Sharon M Moe
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-12

6.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

Authors:  Geoffrey A Block; David M Spiegel; James Ehrlich; Ravindra Mehta; Jill Lindbergh; Albert Dreisbach; Paolo Raggi
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

7.  Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.

Authors:  P A Price; A M Roublick; M K Williamson
Journal:  Kidney Int       Date:  2006-09-06       Impact factor: 10.612

8.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.

Authors:  A Levin; G L Bakris; M Molitch; M Smulders; J Tian; L A Williams; D L Andress
Journal:  Kidney Int       Date:  2006-11-08       Impact factor: 10.612

9.  The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.

Authors:  D Russo; I Miranda; C Ruocco; Y Battaglia; E Buonanno; S Manzi; L Russo; A Scafarto; V E Andreucci
Journal:  Kidney Int       Date:  2007-09-05       Impact factor: 10.612

Review 10.  Mechanisms of vascular calcification in chronic kidney disease.

Authors:  Sharon M Moe; Neal X Chen
Journal:  J Am Soc Nephrol       Date:  2007-12-19       Impact factor: 10.121

View more
  73 in total

1.  Evaluation of hypophosphatemia: lessons from patients with genetic disorders.

Authors:  Justine Bacchetta; Isidro B Salusky
Journal:  Am J Kidney Dis       Date:  2011-11-09       Impact factor: 8.860

Review 2.  The bone-vascular axis in chronic kidney disease.

Authors:  Linda Demer; Yin Tintut
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

Review 3.  Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.

Authors:  Wacharee Seeherunvong; Myles Wolf
Journal:  Pediatr Transplant       Date:  2010-10-08

4.  Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Authors:  Sharon M Moe; Miriam P Zidehsarai; Mary A Chambers; Lisa A Jackman; J Scott Radcliffe; Laurie L Trevino; Susan E Donahue; John R Asplin
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 8.237

Review 5.  Pathophysiology of Vascular Calcification.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

6.  Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.

Authors:  Matthew R Allen; Neal X Chen; Vincent H Gattone; Sharon M Moe
Journal:  Am J Nephrol       Date:  2013-11-22       Impact factor: 3.754

7.  Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.

Authors:  Keith G Avin; Julian A Vallejo; Neal X Chen; Kun Wang; Chad D Touchberry; Marco Brotto; Sarah L Dallas; Sharon M Moe; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-20       Impact factor: 4.310

8.  Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.

Authors:  Erin M B McNerny; Dorothy T Buening; Mohammad W Aref; Neal X Chen; Sharon M Moe; Matthew R Allen
Journal:  Bone       Date:  2019-05-03       Impact factor: 4.398

Review 9.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

10.  Fibroblast Growth Factor-23 and a Vegetarian Diet.

Authors:  Shuchi Anand; Ram Jagannathan; Ruby Gupta; Sailesh Mohan; Dorairaj Prabhakaran; Myles Wolf
Journal:  J Ren Nutr       Date:  2020-04-01       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.